Pressorol en es it fr

Pressorol Brand names, Pressorol Analogs

Pressorol Brand Names Mixture

  • No information avaliable

Pressorol Chemical_Formula


Pressorol RX_link

Pressorol fda sheet

Pressorol msds (material safety sheet)

Pressorol MSDS

Pressorol Synthesis Reference

Brit. pat. 353,361 (1930 to I. G. Farben); Brit. pat. 396,951 (1932 to I. G. Farben); Swiss pat. 162,267 (1931 to I. G. Farben); U.S. pats. 1,948,162 ans 1,951,302; Hartung, U.S. pat. 1,995,709 (1935 to Sharp & Dohme)

Pressorol Molecular Weight

167.205 g/mol

Pressorol Melting Point

107.5 oC

Pressorol H2O Solubility

1000 g/L

Pressorol State


Pressorol LogP


Pressorol Dosage Forms

Intramuscular injection; Intravenous injection

Pressorol Indication

For the treatment and prevention of hypotension due to hemorrhage, spinal anesthesia, and shock associated with brain damage

Pressorol Pharmacology

Metaraminol is a potent sympathomimetic amine that increases both systolic and diastolic blood pressure. Metaraminol is indicated for prevention and treatment of the acute hypotensive state occurring with spinal anesthesia. It is also indicated as adjunctive treatment of hypotension due to hemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to trauma or tumor. Metaraminol acts on both α1-adrenergic receptors but appears to have no effect on β-adrenergic receptors. It acts by increasing the force of the heart's pumping action as well as constricting peripheral blood vessels.

Pressorol Absorption

The effect starts 1-2 min after IV injection, 10 min after IM injection, 5-20 min after subcutaneous injection.

Pressorol side effects and Toxicity

LD50=240 mg/kg (rat, oral); LD50=99 mg/kg (mouse, oral)

Pressorol Patient Information

Pressorol Organisms Affected

Humans and other mammals